ICU Medical, Incorporated (NASDAQ:ICUI) Shares Sold by Metropolitan Life Insurance Co. NY

Metropolitan Life Insurance Co. NY cut its stake in shares of ICU Medical, Incorporated (NASDAQ:ICUI) by 40.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,213 shares of the medical instruments supplier’s stock after selling 3,525 shares during the quarter. Metropolitan Life Insurance Co. NY’s holdings in ICU Medical were worth $1,531,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Millennium Management LLC increased its position in ICU Medical by 5.9% during the 1st quarter. Millennium Management LLC now owns 548,769 shares of the medical instruments supplier’s stock worth $138,509,000 after purchasing an additional 30,676 shares in the last quarter. JPMorgan Chase & Co. increased its position in ICU Medical by 6.8% during the 1st quarter. JPMorgan Chase & Co. now owns 472,988 shares of the medical instruments supplier’s stock worth $119,382,000 after purchasing an additional 29,977 shares in the last quarter. Renaissance Technologies LLC increased its position in ICU Medical by 1.1% during the 2nd quarter. Renaissance Technologies LLC now owns 312,500 shares of the medical instruments supplier’s stock worth $91,766,000 after purchasing an additional 3,400 shares in the last quarter. Northern Trust Corp increased its position in ICU Medical by 21.3% during the 1st quarter. Northern Trust Corp now owns 246,976 shares of the medical instruments supplier’s stock worth $62,337,000 after purchasing an additional 43,410 shares in the last quarter. Finally, OppenheimerFunds Inc. increased its position in ICU Medical by 58.1% during the 2nd quarter. OppenheimerFunds Inc. now owns 225,807 shares of the medical instruments supplier’s stock worth $66,308,000 after purchasing an additional 82,976 shares in the last quarter. 74.29% of the stock is owned by hedge funds and other institutional investors.

In other ICU Medical news, VP Virginia Ruth Sanzone sold 787 shares of the company’s stock in a transaction that occurred on Tuesday, August 28th. The stock was sold at an average price of $303.12, for a total value of $238,555.44. Following the transaction, the vice president now directly owns 1,367 shares of the company’s stock, valued at approximately $414,365.04. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Pfizer Inc sold 700,000 shares of the company’s stock in a transaction that occurred on Monday, August 13th. The shares were sold at an average price of $284.35, for a total value of $199,045,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 711,920 shares of company stock worth $202,651,956 over the last three months. 12.50% of the stock is currently owned by corporate insiders.

Several research firms have commented on ICUI. Zacks Investment Research cut ICU Medical from a “strong-buy” rating to a “hold” rating in a report on Thursday. ValuEngine upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Tuesday, October 2nd. BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Friday, September 28th. Finally, TheStreet upgraded ICU Medical from a “c+” rating to a “b+” rating in a report on Monday, August 20th. One analyst has rated the stock with a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $337.00.

Shares of NASDAQ:ICUI traded up $4.95 during trading on Friday, reaching $265.80. 167,031 shares of the stock were exchanged, compared to its average volume of 157,986. ICU Medical, Incorporated has a 12-month low of $180.45 and a 12-month high of $321.70. The stock has a market capitalization of $5.79 billion, a P/E ratio of 48.15 and a beta of 0.41.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Thursday, August 9th. The medical instruments supplier reported $2.66 EPS for the quarter, topping the consensus estimate of $1.82 by $0.84. The firm had revenue of $360.46 million for the quarter, compared to analyst estimates of $337.60 million. ICU Medical had a return on equity of 12.78% and a net margin of 5.93%. ICU Medical’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.76 EPS. Research analysts expect that ICU Medical, Incorporated will post 7.6 EPS for the current year.

ICU Medical Profile

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Further Reading: Should You Consider an Index Fund?

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply